Patients, medical groups launch campaign in opposition to Trump’s pricing proposal; Diabetes pill considered for FDA approval; The MM&M Podcast teaser.
Court documents detail aggressive marketing of OxyContin; Walgreens partners with Microsoft on research; Allergan wants High Court to take up Restasis patent lawsuit.
Walmart pharmacies set to leave CVS network; Edwards Lifesciences settles patent dispute with Boston Scientific; Pfizer to cut 150 R&D jobs.
With Bristol-Myers Squibb’s acquisition of Celgene set to close in Q3, the two companies have some marketing shops in common.
Hospitals required to post prices; Judge halts new rules on ACA birth control mandate; New global pharma association rules ban gifts to doctors.
Researchers found that spending on medical advertising reached nearly $30 billion in 2016, a $12 billion increase from 1997.
Louisiana adopts ‘Netflix model’ to pay for hepatitis C drug; J&J raises prices; Drug pricing advocacy group launches ad campaign supporting Trump proposals.
“Father of direct marketing” created a trillion-dollar industry.
The CMO laid bare how the brand has been forced to quickly evolve.
Day three at JP Morgan Healthcare Conference; Sanders-Cummings drug-pricing bill introduced; First patient treated under Right to Try Law.